Quest Partners LLC Y M Abs Therapeutics, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 27,135 shares of YMAB stock, worth $131,604. This represents 0.03% of its overall portfolio holdings.
Number of Shares
27,135
Previous 387
6911.63%
Holding current value
$131,604
Previous $5.09 Million
4075.02%
% of portfolio
0.03%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding YMAB
# of Institutions
114Shares Held
27MCall Options Held
5.6KPut Options Held
900-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$20.5 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$14.3 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$13.9 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$10.6 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$9.7 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $212M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...